reMYND
reMYND is a preclinical In-Vivo Alzheimer's Contract Research.
1
Funding Rounds
$14.5m
Money raised
Funding series
Funding Series Analysis
The company reMYND has raised a total of $14.5m in funding over 1 rounds.
Key Insights:
- reMYND Series B round, January 2021: $14.5m
reMYND Series B round, January 2021
$14.5m
Industries
reMYND is active in the following industries: